Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04807907 · ClinicalTrials.gov registry record · NA
Promoting Infant-Directed Speech in Ghana
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 2,800
- Enrollment target
NCT04807907: Completed NA study, sponsored by Northwestern University.
NCT04807907 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 2,800 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04807907, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,800 participants
- Enrollment target
Study Summary
The study is a randomized evaluation of a low-cost intervention that encourages mothers and other caregivers to talk to infants, or to engage in what is known as infant-directed speech (IDS) as a way of promoting language and brain development in Tamale and surrounding areas, Ghana.
Primary Outcome
Number of words spoken to child
Interventions
- BEHAVIORAL Infant Directed Speech (IDS) Video + IDS Wall Calendar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,800 participants |
| Start Date | 2021-03-02 |
| Est. Completion | 2024-06-01 |
| Phase | NA |
What the finished NCT04807907 record still lists
NCT04807907 is an interventional study that assigns participants to a tested intervention. Its 2,800 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% higher).
The record links to 0 conditions, and to 1 intervention - of which Infant Directed Speech (IDS) Video + IDS Wall Calendar is the first listed.
NCT04807907 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04807907 about?
NCT04807907 is a clinical study titled "Promoting Infant-Directed Speech in Ghana". The study is a randomized evaluation of a low-cost intervention that encourages mothers and other caregivers to talk to infants, or to engage in what is known as infant-directed speech (IDS) as a way of promoting language and brain development in Tamale and surrounding areas, Ghana.
What is the current status of trial NCT04807907?
This trial is currently completed. It is a NA study. The enrollment target is 2,800 participants. The study started on 2021-03-02. Estimated completion is 2024-06-01.
What interventions are being tested in trial NCT04807907?
The interventions under investigation include: Infant Directed Speech (IDS) Video + IDS Wall Calendar (BEHAVIORAL).
Who is sponsoring clinical trial NCT04807907?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04807907's enrollment target sits among peer trials
2,800 43rd of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05443737 · 2,800 participants · Phase 3
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
- NCT05899439 · 2,800 participants
Immune Function and the Progression to T1D
- NCT06089109 · 2,800 participants · NA
Creating VIP Corps to Reduce Maternal Deaths
- NCT06345339 · 2,800 participants · Phase 2
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI